Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cancer Biology & Medicine|May 24, 2019
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancerYuxiang Wang, Xian Li, Xueling Liu, et al.European Journal of Medicinal Chemistry|August 20, 2016
Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorptionXing Xu, Xueyu Qi, Yufei Yan, et al.Journal of Inflammation (London, England)|May 23, 2021
VEGF as a potential molecular target in periodontitis: a meta-analysis and microarray data validationBo Ren, Que Feng, Shan He, et al.Biochemical Pharmacology|January 18, 2016
Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 proteinXia Liu, Zhijian Xu, Chuanwei Hou, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 16, 2018
A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone LossMin Jiang, Tianqi Wang, Xueming Yan, et al.Journal of Medicinal Chemistry|August 22, 2023
YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP InhibitorsYuting Sun, Hui Yang, Jiaqi Yuan, et al.Journal of Medicinal Chemistry|May 15, 2019
Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit OptimizationMin Jiang, Lei Peng, Kai Yang, et al.Signal Transduction and Targeted Therapy|April 11, 2023
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitorsXu Zhang, Yuxiang Wang, Xi Zhang, et al.Signal Transduction and Targeted Therapy|April 25, 2021
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Yiyue Ge, Tingzhong Tian, Suling Huang, et al.Pageof 9